China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 224 full-time employees. The company went IPO on 2000-02-15. The firm's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The firm manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
CPHI stock price ended at $1.24 on 金曜日, after dropping 1.59%
On the latest trading day Jan 23, 2026, the stock price of CPHI fell by 1.59%, dropping from $1.27 to $1.24. During the session, the stock saw a volatility of 2.42%, with prices oscillating between a daily low of $1.24 and a high of $1.27. On the latest trading day, the trading volume for CPHI rose by 2.9K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 6.2K shares were traded, with a market value of approximately $6.2M.